leflunomide has been researched along with Churg-Strauss Syndrome in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Churg-Strauss Syndrome: Widespread necrotizing angiitis with granulomas. Pulmonary involvement is frequent. Asthma or other respiratory infection may precede evidence of vasculitis. Eosinophilia and lung involvement differentiate this disease from POLYARTERITIS NODOSA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, JJY | 1 |
Alsaleem, A | 1 |
Chiang, GPK | 1 |
Limenis, E | 1 |
Sontichai, W | 1 |
Yeung, RSM | 1 |
Akikusa, J | 1 |
Laxer, RM | 1 |
Moosig, F | 1 |
Bremer, JP | 1 |
Hellmich, B | 1 |
Holle, JU | 1 |
Holl-Ulrich, K | 1 |
Laudien, M | 1 |
Matthis, C | 1 |
Metzler, C | 1 |
Nölle, B | 1 |
Richardt, G | 1 |
Gross, WL | 1 |
1 review available for leflunomide and Churg-Strauss Syndrome
Article | Year |
---|---|
Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
Topics: Adult; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathio | 2019 |
1 other study available for leflunomide and Churg-Strauss Syndrome
Article | Year |
---|---|
A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients.
Topics: Anti-Inflammatory Agents; Azathioprine; Churg-Strauss Syndrome; Cohort Studies; Cyclophosphamide; Fe | 2013 |